S
27.56
0.15 (0.55%)
前收盘价格 | 27.41 |
收盘价格 | 27.42 |
成交量 | 305,507 |
平均成交量 (3个月) | 898,392 |
市值 | 13,239,933,952 |
市盈率 (P/E TTM) | 25.76 |
预期市盈率 (P/E Forward) | 25.97 |
价格/销量 (P/S) | 1.47 |
股市价格/股市净资产 (P/B) | 1.67 |
52周波幅 | |
利润日期 | 20 Feb 2025 |
股息率 (DY TTM) | 3.85% |
营业毛利率 | 5.70% |
营业利益率 (TTM) | 10.69% |
稀释每股收益 (EPS TTM) | 1.07 |
季度收入增长率 (YOY) | 14.10% |
季度盈利增长率 (YOY) | 2.00% |
总债务/股东权益 (D/E MRQ) | 55.92% |
流动比率 (MRQ) | 1.01 |
营业现金流 (OCF TTM) | 1.07 B |
杠杆自由现金流 (LFCF TTM) | 427.14 M |
资产报酬率 (ROA TTM) | 3.88% |
股东权益报酬率 (ROE TTM) | 6.80% |
市场趋势
短期 | 中期 | ||
行业 | Diagnostics & Research (AU) | 混合的 | 混合的 |
Diagnostics & Research (全球的) | 混合的 | 混合的 | |
股票 | SONIC HLTH FPO [SHL] | - | - |
AIStockmoo 评分
1.3
分析师共识 | 0.0 |
内部交易活动 | NA |
价格波动 | -1.0 |
技术平均移动指标 | 1.0 |
技术振荡指标 | 5.0 |
平均 | 1.25 |
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe. |
|
部门 | Healthcare |
行业 | Diagnostics & Research |
投资方式 | Large Core |
内部持股比例 | 5.37% |
机构持股比例 | 42.46% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合